Join the Coronary Artery Disease (CAD) group to help and get support from people like you.
Coronary Artery Disease (CAD) News (Page 2)
Related terms: Arteriosclerotic Heart Disease, Coronary Heart Disease (CHD), Coronary Heart Disease, CAD, CHD
Primary Prevention Aspirin Use Decreased After Recommendation Change
FRIDAY, Jan. 24, 2025 – Among older adults and adults with low atherosclerotic cardiovascular disease (ASCVD) risk for whom aspirin is not recommended, use of aspirin decreased after 2019 changes in...
Coronary Artery Disease Common in Patients With Cirrhosis
FRIDAY, Dec. 20, 2024 – Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with an increased CAD risk, according to a review...
CORSWO Model Stratifies Women According to Coronary Risk
FRIDAY, Dec. 13, 2024 – The Coronary Risk Score in Women (CORSWO) can predict the risk of major adverse cardiovascular events (MACE), according to a study published online Dec. 5 in Radiology:...
Model Including Polygenic Risk, Polysocial Score Improves CHD Risk Prediction
THURSDAY, Dec. 12, 2024 – A prediction model incorporating a polygenic risk score (PRS) and polysocial score (PSS), including social determinants of health and lifestyle-psychological factors,...
U-Shaped Association Seen for Alcohol Consumption, Cardiometabolic Disease
FRIDAY, Dec. 6, 2024 – There is a U-shaped association between alcohol consumption and coronary heart disease (CHD) and type 2 diabetes (T2D) but no evidence for a causal association, according to a...
Hourglass-Shaped Stent Might Ease Tough-to-Treat Angina
MONDAY, Nov. 11, 2024 – Recurring angina chest pain in people with a certain type of heart disease can be tough to treat, but a new hourglass-shaped stent could be a real advance, researchers...
Orbital Atherectomy No Better Than Balloon Angioplasty
MONDAY, Nov. 4, 2024 – For patients with severely calcified coronary lesions, routine treatment with orbital atherectomy prior to drug-eluting stent implantation does not yield greater minimal stent...
Black Patients 22% More Likely to Die After Bypass Surgeries
TUESDAY, Oct. 22, 2024 – Heart bypass operations have gotten safer, but not everyone is benefiting equally: New data shows that Black patients face a 22% higher odds of dying in the hospital after...
COVID-19 Hospitalization Equivalent to Coronary Artery Disease for MACE Risk
WEDNESDAY, Oct. 9, 2024 – Hospitalization for COVID-19 represents a coronary artery disease risk equivalent, contributing to an increased risk for major adverse cardiovascular events (MACE),...
FDA Approves Norliqva (amlodipine) Oral Solution for Hypertension and Coronary Artery Disease
February 28, 2022 - The U.S. Food and Drug Administration has approved Norliqva (amlodipine) oral solution for the treatment of: Hypertension in adults and children 6 years and older, to lower blood...
Brilinta Approved in the US to Reduce the Risk of a First Heart Attack or Stroke in High-Risk Patients with Coronary Artery Disease
June 1, 2020 – AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of a first heart attack or stroke in high-risk patients with coronary artery disease (CAD), the most ...
FDA Approves Gadavist (gadobutrol) Contrast Agent for Use in Cardiac MR in Adult Patients with Known or Suspected Coronary Artery Disease
WHIPPANY, N.J., July 15, 2019 /PRNewswire/ – Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use in cardiac magnetic resonance (MR)...
FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older
WOBURN, Mass. (July 10, 2019) – Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, ann...
FDA Approves Xarelto to Reduce the Risk of Major Cardiovascular Events in Patients with Chronic Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD)
TITUSVILLE, NJ, October 11, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved Xarelto (rivaroxaban) to r...
Further information
Related drug support groups
lisinopril, amlodipine, Xarelto, Brilinta, Norvasc, rivaroxaban, garlic, ticagrelor